Literature DB >> 3192450

Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985).

C Prymak1, L J McKee, M H Goldschmidt, L T Glickman.   

Abstract

Data on age, sex, and breed were obtained from surgical pathologic records of 92 dogs with splenic hemangiosarcoma (SHS) and for 125 dogs with splenic hematoma (SHA) diagnosed in 1985 at the University of Pennsylvania School of Veterinary Medicine. Further information on body weight, clinical and surgical findings, and survival time was obtained for 59 dogs (64.1%) with SHS and 91 dogs (72.8%) with SHA. Splenic hemangiosarcoma was markedly more common in dogs 8 to 13 years old, and SHA was appreciably more common in dogs greater than or equal to 8 years old, compared with dogs 1 to 7 years old. Compared with sexually intact females, only spayed females were at significantly (odds ratio [or], 2.2; 95% confidence interval [CI], 1.2 to 4.1) increased risk for developing SHS; sex predisposition was not found for dogs with SHA. The German Shepherd Dog was the only breed with increased risk for development of either SHS (OR, 4.7; 95% CI, 2.7 to 7.8) or SHA (OR, 2.8; 95% CI, 1.7 to 4.9), compared with all other purebred dogs. Association of tumor type for 7 commonly reported clinical signs with observance of hemoperitoneum at surgery was determined; anorexia (P = 0.01), collapse (P = 0.01), and hemoperitoneum (P less than 0.001) were significantly more common in dogs with SHS. The median survival time for dogs with SHS was 19 days, compared with 338 days for dogs with SHA (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3192450

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  34 in total

1.  Comparative evaluation of the liver in dogs with a splenic mass by using ultrasonography and contrast-enhanced computed tomography.

Authors:  Roelof A Irausquin; Thomas D Scavelli; Lisa Corti; Joseph D Stefanacci; Joann DeMarco; Shannon Flood; Barton W Rohrbach
Journal:  Can Vet J       Date:  2008-01       Impact factor: 1.008

2.  Primary peri-aortic hemangiosarcoma in a dog.

Authors:  Justin Guinan; Anthony Fischetti; Ana Paula Garate; Serge Chalhoub
Journal:  Can Vet J       Date:  2012-11       Impact factor: 1.008

3.  Outcome and prognostic factors for dogs with a histological diagnosis of splenic hematoma following splenectomy: 35 cases (2001-2013).

Authors:  Steve G Patten; Sarah E Boston; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2016-08       Impact factor: 1.008

4.  Sudden death due to acute hemoabdomen and hypovolemia from a ruptured splenic hemangiosarcoma in a German shepherd dog.

Authors:  Brittany Lang
Journal:  Can Vet J       Date:  2020-11       Impact factor: 1.008

5.  Canine hemangiosarcoma in a female Jindo dog.

Authors:  Ahlyum Mun; Eun-Mi Lee; Ah-Young Kim; Eun-Joo Lee; Il-Hwa Hong; Kyu-Shik Jeong
Journal:  Lab Anim Res       Date:  2011-12-19

Review 6.  Domestic dogs and cancer research: a breed-based genomics approach.

Authors:  Brian W Davis; Elaine A Ostrander
Journal:  ILAR J       Date:  2014

Review 7.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

8.  Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed.

Authors:  Beth A Tamburini; Susan Trapp; Tzu Lip Phang; Jill T Schappa; Lawrence E Hunter; Jaime F Modiano
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

9.  Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma.

Authors:  Heather Wilson-Robles; Tasha Miller; Jill Jarvis; Jason Terrell; Theresa Kathleen Kelly; Thomas Bygott; Mhammed Bougoussa
Journal:  BMC Vet Res       Date:  2021-06-29       Impact factor: 2.741

10.  Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.

Authors:  Dorothy Cimino Brown; Jennifer Reetz
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.